Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$277,573,909
New position
Shares Held
1,463,843
first reported quarter
Ownership
0.094%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#85
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caisse de depot et placement du Quebec holds $3,472,564,051 across 11 Drug Manufacturers - General names. AZN ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
805,809 | $966,511,569 | |
| 2 | JNJ |
Johnson & Johnson
|
2,259,196 | $573,768,008 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,448,107 | $571,581,749 | |
| 4 | ABBV |
AbbVie Inc.
|
1,641,631 | $413,100,024 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,463,843 | $277,573,909 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,083,390 | $263,215,492 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,228,503 | $243,646,342 | |
| 8 | BIIB |
Biogen Inc.
|
510,194 | $110,232,515 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,573,909 | 1,463,843 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||